North America Lipid POCT Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • May 2021
  • North America
  • 350 Pages
  • No of Tables: 92
  • No of Figures: 34

North America Lipid POCT Market, By Type (Instruments, Consumables and Kits), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial hypercholesterolemia, Tangier Disease, Others), Mode (Prescription-Based Testing, OTC-Based Testing), Brand (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek, Others), Platform (Lateral Flow Assays (Immunochromatography Tests), Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Hospitals, Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028

North America Lipid POCT Market Market Analysis and Insights: North America Lipid POCT Market

The lipid POCT market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.9% in the forecast period of 2021 to 2028 and is expected to reach USD 457.20 million by 2028. The rise in the number of chronic infections has led to people opting for point-of-care kits and products for testing and therefore this will drive the growth of the lipid POCT market.

POCT is characterized as testing which can be done close to the patient where a medical decision can be made immediately including the results and monitoring. Lipid POCT is also called with-patient testing of lipid and allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes as compared to hours.

The new biotechnological advancements have been creating immense boosting factors and drive the growth of the lipid POCT market. The high cost of products can hamper the growth of the lipid POCT market. The rising healthcare expenditure is expected to act as an opportunity for the growth of the lipid POCT market. The lack of alignment with test results obtained from laboratories is creating an immense challenge for the lipid POCT market.

The lipid POCT market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the lipid POCT market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Lipid POCT Market Lipid POCT Market Scope and Market Size

The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
  • On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
  • On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
  • On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
  • On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
  • On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
  • On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.

Lipid POCT Market Country Level Analysis

The lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.

The countries covered in North America lipid POCT market are U.S., Canada and Mexico.

The U.S. is dominating the market due to increasing prevalence of chronic diseases and rising technological advancements.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market

The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Lipid POCT Market Share Analysis

The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to lipid POCT market.

The major companies providing lipid POCT products in North America lipid POCT market are Abbott, F.Hoffmann-La Roche Ltd., and Nova Biomedical, Calligari Srl, AMD SOLUTIONS, EuroMedix, Siemens Healthcare GmbH (A Subsidiary of Siemens), Jant Pharmacal Corporation, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, ACON Laboratories, Inc., PRIMA Lab SA, Quest Diagnostics Incorporated, and SKYLA CORPORATION among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.

For instance,

  • In November 2020, SD Biosensor, INC. announced its partnership with DKSH Korea to develop pharmacy blood sugar business. This will help the company to diversify its market in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the lipid POCT market which also provides the benefit for organisation to improve their offering for lipid POCT market.

Customization Available: North America Lipid POCT Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:

TABLE 1 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)

TABLE 15 NORTH AMERICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 50 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 U.S. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 U.S. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.S. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 U.S. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 58 U.S. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 U.S. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 U.S. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 61 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 62 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 63 U.S. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 64 U.S. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 U.S. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 U.S. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 CANADA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 CANADA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 CANADA ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 70 CANADA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 71 CANADA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 CANADA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 CANADA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 74 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 75 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 76 CANADA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 77 CANADA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 CANADA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 CANADA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 MEXICO LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 MEXICO INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 MEXICO ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 83 MEXICO ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 84 MEXICO CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 MEXICO LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 MEXICO LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 87 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 88 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 89 MEXICO LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 90 MEXICO LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 MEXICO PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 MEXICO LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions